Vanberra Signal

Factorial Biotechnologies

Curated by Signal

Provider of single-cell sequencing technology for research

Overview

Provider of single-cell sequencing technology for research. It offers platform technology to design WGS and RNA libraries within a single cell for clinical application which includes targeted cancer therapy, immunotherapy, CRISPR, and cell and gene therapy.

Key facts

Founded
2021

Business model

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Developer of a robotic surgical integrated system

    Life Sciences TechnologyBoston, United States
  • Digital electromyography data reporting tool for providers

    Life Sciences TechnologyPhoenix, United States
  • Personalized supplements for women

    Life Sciences TechnologyPhiladelphia, United States

About Factorial Biotechnologies

What does Factorial Biotechnologies do?

Provider of single-cell sequencing technology for research.

Where is Factorial Biotechnologies headquartered?

Factorial Biotechnologies is headquartered in San Carlos, United States.

When was Factorial Biotechnologies founded?

Factorial Biotechnologies was founded in 2021.

Which sector is Factorial Biotechnologies in?

Factorial Biotechnologies operates in Life Sciences Technology.

Who are Factorial Biotechnologies's competitors?

Companies similar to Factorial Biotechnologies include Activ Surgical, Noraxon, and BINTO.